FDA approves new drug for eczema
On March 28, the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema. Read more
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.